Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide (Q85062314)
Jump to navigation
Jump to search
scientific article published on September 19, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide |
scientific article published on September 19, 2010 |
Statements
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide (English)
Mohamed Mursal
Athina Zacharia
Kathy Ciano
Steven Khoo
Alexander Stojadinovic
Sathibalan Ponniah
Jeremy D. Gates
Guy T. Clifton
Linda C. Benavides
Alan K. Sears
Mark G. Carmichael
Matthew T. Hueman
Jarrod P. Holmes
Yusuf H. Jama
19 September 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference